The Native Antigen Company Ltd

13 articles about The Native Antigen Company Ltd

• The Native Antigen Company Expands Infectious Disease Portfolio to Include Sudan Ebolavirus Boniface 1976 Glycoprotein

  12/8/2022

  The Native Antigen Company announced the commercial release of its Sudan Ebolavirus Boniface 1976 Glycoprotein.

• The Native Antigen Company Strengthens Senior Team to Support Growing Product Portfolio

  11/23/2022

  The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, announced two key appointments to its management team.

• 

  Global Roundup: DBI and Bayer Partner on Sleep Apnea Solution and More

  6/17/2021

  Biopharma and life sciences companies from across the globe provide updates on their business operations and pipelines.
• 

  BioSpace Global Roundup, Oct. 8

  10/8/2020

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

• The Native Antigen Company Launches Range of SARS-CoV-2 Specific Antibodies

  10/7/2020

  The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, announced the introduction of ten new monoclonal antibodies recognising SARS-CoV-2, the causative agent of COVID-19.

• 

  BioSpace Global Roundup, Aug. 20

  8/20/2020

  Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

• LGC Acquires The Native Antigen Company, Strengthening its Offer to the IVD Sector

  7/9/2020

  LGC announced the acquisition of The Native Antigen Company, one of the world’s leading suppliers of high quality infectious disease antigens and antibodies.

• The Native Antigen Company Introduces Novel Coronavirus Antigens

  2/12/2020

  Newly developed recombinant antigens derived specifically from 2019-nCoV for use in infectious disease research, and assay and vaccine development

• The Native Antigen Company Ltd Expands Into New Development And Production Facilities And Introduces New Services

  5/2/2017

• The Native Antigen Company Ltd Announces a World First: the Release of all 4 Dengue Virus NS1 Serotypes From Human Cell Lines

  10/17/2013

• The Native Antigen Company Ltd Releases Dengue Virus Serotype 2 NS1 Protein

  6/20/2013

• The Native Antigen Company Ltd: Toxins & Toxoids of Clostridium Difficile Ribotypes 027 and 078

  4/5/2013

• The Native Antigen Company Ltd Release: New - Highly Purified, Cost-Effective CMV Native Antigen for IgM

  1/3/2012